Medicare Enrolled
Dr. Michael Scola, M.D.
Hematology & Oncology · Morristown, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Scola from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scola?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Scola
Dr. Michael Scola is a hematology & oncology specialist in Morristown, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scola performed 3,531 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Scola received a total of $555,250 from 66 pharmaceutical and/or device companies across 1316 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scola is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 38% volume in NJ
$555,250 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,531
Medicare services
Top 38% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
763 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
760 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
556 | $100 | $363 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
447 | $67 | $240 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
325 | $145 | $488 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
295 | $101 | $343 |
| New patient office visit, complex (60-74 min) | 119 | $181 | $691 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
110 | $147 | $733 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
49 | $34 | $35 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
47 | $72 | $93 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $111 | $449 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $125 | $551 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$555,250
Total received (2018-2024)
Avg $79,321/year across 7 years
Top 1% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,316
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$53,438
2023
$48,079
2022
$69,373
2021
$67,349
2020
$79,417
2019
$112,699
2018
$124,894
Payments by company (2024)
Incyte Corporation
$51,107
PFIZER INC.
$498
GENZYME CORPORATION
$321
E.R. Squibb & Sons, L.L.C.
$205
Daiichi Sankyo Inc.
$198
Gilead Sciences, Inc.
$155
AstraZeneca Pharmaceuticals LP
$154
Celgene Corporation
$103
Janssen Biotech, Inc.
$103
Mirati Therapeutics, Inc.
$93
GlaxoSmithKline, LLC.
$90
Merck Sharp & Dohme LLC
$53
Eisai Inc.
$52
Astellas Pharma US Inc
$45
Lilly USA, LLC
$37
ARRAY BIOPHARMA INC
$35
Bayer Healthcare Pharmaceuticals Inc.
$22
ImmunoGen, Inc.
$21
Exelixis Inc.
$19
EMD Serono, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
Stemline Therapeutics Inc.
$17
TAIHO ONCOLOGY, INC.
$16
Genmab U.S., Inc.
$16
Pharmacosmos Therapeutics Inc.
$16
Galvanize Therapeutics, Inc
$16
Regeneron Healthcare Solutions, Inc.
$13
Top 3 companies account for 97.2% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$488,355
Janssen Pharmaceuticals, Inc
$30,355
Novartis Pharmaceuticals Corporation
$9,245
GlaxoSmithKline, LLC.
$4,637
GENZYME CORPORATION
$4,388
E.R. Squibb & Sons, L.L.C.
$3,501
CTI BioPharma Corp.
$2,590
AVEO Pharmaceuticals, Inc.
$1,815
Celgene Corporation
$1,505
PFIZER INC.
$884
Seagen Inc.
$876
Astellas Pharma US Inc
$650
Daiichi Sankyo Inc.
$569
Merck Sharp & Dohme LLC
$485
AstraZeneca Pharmaceuticals LP
$461
Janssen Biotech, Inc.
$438
Gilead Sciences, Inc.
$398
Amgen Inc.
$315
Regeneron Healthcare Solutions, Inc.
$280
Mirati Therapeutics, Inc.
$277
Eisai Inc.
$265
Genentech USA, Inc.
$263
Karyopharm Therapeutics Inc.
$218
Merck Sharp & Dohme Corporation
$212
Kite Pharma, Inc.
$208
Takeda Pharmaceuticals U.S.A., Inc.
$188
Seattle Genetics, Inc.
$171
ImmunoGen, Inc.
$154
Pharmacyclics LLC, An AbbVie Company
$125
Foundation Medicine, Inc.
$112
Lilly USA, LLC
$104
EISAI INC.
$101
Pharmacosmos Therapeutics Inc.
$79
AbbVie Inc.
$69
JAZZ PHARMACEUTICALS INC.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
EUSA Pharma (US) LLC
$59
Puma Biotechnology, Inc.
$52
Genmab U.S., Inc.
$49
ARRAY BIOPHARMA INC
$45
Epizyme, Inc.,
$44
TAIHO ONCOLOGY, INC.
$34
Ipsen Biopharmaceuticals, Inc
$34
Adaptive Biotechnologies Corporation
$33
EMD Serono, Inc.
$32
Exelixis Inc.
$32
SERVIER PHARMACEUTICALS LLC
$32
MorphoSys, US Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$30
Taiho Oncology, Inc.
$30
Jazz Pharmaceuticals Inc.
$29
Rigel Pharmaceuticals, Inc.
$27
Lexicon Pharmaceuticals, Inc.
$26
Acrotech Biopharma LLC
$25
Bayer Healthcare Pharmaceuticals Inc.
$22
Sirtex Medical Inc
$20
MACROGENICS, INC.
$18
ABBVIE INC.
$17
Stemline Therapeutics Inc.
$17
Galvanize Therapeutics, Inc
$16
Acceleron Pharma, Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$15
SANOFI-AVENTIS U.S. LLC
$14
Duchesnay USA Incorporated
$14
Alexion Pharmaceuticals, Inc.
$14
TerSera Therapeutics LLC
$12
Top 3 companies account for 95.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIYA SYSTEM · Alecensa · Asparlas · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · Blincyto · CABOMETYX · CALQUENCE · CAMZYOS · CEREZYME · COSELA · CREON · CYRAMZA · Cabometyx · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ENHERTU · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FOTIVDA · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nerlynx · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · Padcev · Pomalyst · Prolia · REBLOZYL · Reblozyl · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Siklos · Stivarga · Sylvant · TALVEY · TASIGNA · TAZVERIK · TECVAYLI · TEPMETKO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
183
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Scola is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Scola experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Scola performed 763 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Scola receive payments from pharmaceutical companies?
Yes. Dr. Scola received a total of $555,250 from 66 companies across 1,316 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scola's costs compare to other hematology & oncology specialists in Morristown?
Dr. Scola's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scola) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Morristown
Browse hematology & oncology specialists in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology